Osaic Holdings’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.22K | Sell |
7,025
-900
| -11% | -$1.18K | ﹤0.01% | 5822 |
|
2025
Q1 | $12.8K | Buy |
7,925
+1,500
| +23% | +$2.42K | ﹤0.01% | 5600 |
|
2024
Q4 | $8.1K | Sell |
6,425
-3,864
| -38% | -$4.87K | ﹤0.01% | 5840 |
|
2024
Q3 | $19.3K | Sell |
10,289
-216
| -2% | -$406 | ﹤0.01% | 5362 |
|
2024
Q2 | $77.4K | Buy |
10,505
+355
| +3% | +$2.61K | ﹤0.01% | 4331 |
|
2024
Q1 | $80.9K | Buy |
10,150
+3,500
| +53% | +$27.9K | ﹤0.01% | 4382 |
|
2023
Q4 | $33.8K | Sell |
6,650
-666
| -9% | -$3.38K | ﹤0.01% | 5145 |
|
2023
Q3 | $43.3K | Buy |
7,316
+4,500
| +160% | +$26.6K | ﹤0.01% | 5075 |
|
2023
Q2 | $20.8K | Hold |
2,816
| – | – | ﹤0.01% | 5514 |
|
2023
Q1 | $26.4K | Sell |
2,816
-200
| -7% | -$1.87K | ﹤0.01% | 5381 |
|
2022
Q4 | $33K | Buy |
3,016
+200
| +7% | +$2.19K | ﹤0.01% | 5210 |
|
2022
Q3 | $21K | Hold |
2,816
| – | – | ﹤0.01% | 5524 |
|
2022
Q2 | $14K | Hold |
2,816
| – | – | ﹤0.01% | 5825 |
|
2022
Q1 | $13K | Buy |
2,816
+1,000
| +55% | +$4.62K | ﹤0.01% | 5938 |
|
2021
Q4 | $12K | Sell |
1,816
-1,396
| -43% | -$9.23K | ﹤0.01% | 6081 |
|
2021
Q3 | $28K | Buy |
3,212
+614
| +24% | +$5.35K | ﹤0.01% | 5519 |
|
2021
Q2 | $20K | Buy |
2,598
+375
| +17% | +$2.89K | ﹤0.01% | 5635 |
|
2021
Q1 | $17K | Buy |
2,223
+977
| +78% | +$7.47K | ﹤0.01% | 5551 |
|
2020
Q4 | $9K | Buy |
1,246
+365
| +41% | +$2.64K | ﹤0.01% | 5499 |
|
2020
Q3 | $9K | Sell |
881
-1,453
| -62% | -$14.8K | ﹤0.01% | 5281 |
|
2020
Q2 | $25K | Buy |
2,334
+166
| +8% | +$1.78K | ﹤0.01% | 4631 |
|
2020
Q1 | $13K | Buy |
+2,168
| New | +$13K | ﹤0.01% | 4818 |
|